Clebudin to show excellent clinical results against B hepatitis.

Published: 2001-11-19 06:56:00

Updated: 2001-11-19 06:56:00

Clebudin, a new therapeutic agent against B type hepatitis developed by Bukwang, has shown far outstanding clinical profiles compared to drugs already on markets. Its clinical study was reported by Prof. Lee Hyo-suk, Seoul National Univ. Medical School, and Prof. Jaque Maslini of France in the 52th meeting of the American Society of Liver Disease held at Dallas Texas from Nov. 9 to 13.

Prof....

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.